TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance.

Abstract:

:Purpose Increasing evidences revealed that cancer cells with the characteristics of epithelial-mesenchymal transition (EMT) or cancer stem cells (CSC) have high ability of progression, invasion, metastasis and chemoresistance. TWIST1 and BMI1 are crucial transcription factors required for EMT and CSC. Both TWIST1 and BMI1 are up-regulated in various cancers and have a positive correlation with poor prognosis. Although recent results showed that the two molecules function in promoting cancer metastasis and chemoresistance respectively, the correlation of TWIST1 and BMI1 is not well understood. Methods In this review, we summarize recent advance in cancer research focus on TWIST1 and BMI1 in cancer metastasis and chemoresistance, and emphasize the possible link between EMT and CSC. Results Further investigation of TWIST1 and BMI1 cooperately promote CSC proliferation due to EMT-associated effect will help to understand the mechanism of tumor cells metastasis and chemoresistance. Conclusions TWIST1 and BMI1 in cancer cells will be effective targets for treating chemoresistant metastatic lesions.

journal_name

J Cancer

journal_title

Journal of Cancer

authors

Ren H,Du P,Ge Z,Jin Y,Ding D,Liu X,Zou Q

doi

10.7150/jca.14031

subject

Has Abstract

pub_date

2016-05-25 00:00:00

pages

1074-80

issue

9

issn

1837-9664

pii

jcav07p1074

journal_volume

7

pub_type

杂志文章,评审
  • Interaction between fasting blood glucose and tumor embolus in predicting the postoperative prognosis of 4330 Chinese patients with gastrointestinal tract cancer.

    abstract::Objectives: We aimed to investigate the interaction between fasting blood glucose and tumor embolus, and the potential mediation effect of fasting blood glucose on tumor embolus in predicting gastrointestinal tract cancer-specific mortality risk postoperatively. Methods and Results: 4330 patients were consecutively re...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.34843

    authors: Hu D,Zhang X,Lin X,Zhang H,Xia Y,Lin J,Zheng X,Peng F,Niu W

    更新日期:2020-01-01 00:00:00

  • MicroRNA-204-5p inhibits invasion and metastasis of laryngeal squamous cell carcinoma by suppressing forkhead box C1.

    abstract::Background and aim: Understanding the molecular biological mechanisms underlying laryngeal squamous cell carcinoma (LSCC) invasion and metastasis is crucial for diagnosis, treatment, and prognosis. We aimed to examine the expression of the tumor suppressor microRNA-204-5p (miR-204-5p) and its target gene, forkhead box...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.19470

    authors: Gao W,Wu Y,He X,Zhang C,Zhu M,Chen B,Liu Q,Qu X,Li W,Wen S,Wang B

    更新日期:2017-07-21 00:00:00

  • Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067.

    abstract::Objectives: Chordomas are slow-growing malignancies that commonly affect vital neurological structures. These neoplasms are highly resistant to current chemotherapeutic regimens and often recur after surgical intervention. Therefore, there is an urgent need to identify molecular targets and more robust drugs to improv...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.35426

    authors: Shen S,Dean DC,Yu Z,Hornicek F,Kan Q,Duan Z

    更新日期:2020-01-01 00:00:00

  • Daily Pomegranate Intake Has No Impact on PSA Levels in Patients with Advanced Prostate Cancer - Results of a Phase IIb Randomized Controlled Trial.

    abstract::Pomegranate has been shown to prolong PSA doubling time in early prostate cancer, but no data from a placebo controlled trial has been published yet. The objective of this study was to prospectively evaluate the impact of pomegranate juice in patients with prostate cancer. We conducted a phase IIb, double blinded, ran...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.7123

    authors: Stenner-Liewen F,Liewen H,Cathomas R,Renner C,Petrausch U,Sulser T,Spanaus K,Seifert HH,Strebel RT,Knuth A,Samaras P,Müntener M

    更新日期:2013-08-29 00:00:00

  • Epithelioid Trophoblastic Tumors: Treatments, Outcomes, and Potential Therapeutic Targets.

    abstract::Background: Epithelioid trophoblastic tumors (ETTs) are the rarest type of gestational trophoblastic neoplasias. We investigated the clinical features, treatments, outcomes, and prognostic factors in patients with ETT, and explored potential therapeutic targets. Methods: We retrospectively analyzed the clinical featur...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.28134

    authors: Yang J,Zong L,Wang J,Wan X,Feng F,Xiang Y

    更新日期:2019-01-01 00:00:00

  • Long noncoding RNA LINC01391 restrained gastric cancer aerobic glycolysis and tumorigenesis via targeting miR-12116/CMTM2 axis.

    abstract::Increasing studies indicate that long noncoding RNA (lncRNA) plays a critical role in aerobic glycolysis of various tumors. However, the contribution of lncRNA in gastric cancer (GC) cell glycolysis is still poorly understood. The objective of this research was to investigate the functional role and mechanism of lncRN...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.48365

    authors: Qian C,Xu Z,Chen L,Wang Y,Yao J

    更新日期:2020-08-27 00:00:00

  • Adjuvant Radiochemotherapy versus Chemotherapy Alone for Gastric Cancer: Implications for Target Definition.

    abstract::The INT0116 trial was a milestone study and laid the foundation for the adjuvant radiotherapy (RT) associated to concurrent chemotherapy (CT) for the treatment of gastric cancer (GC) after gastrectomy. However, it is still controversial whether adding RT to CT could further benefit D2-dissected GC patients. The ARTIST...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.27335

    authors: Xu J,Zhu J,Wei Q

    更新日期:2019-01-01 00:00:00

  • Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma.

    abstract::Hepatocellular carcinoma (HCC) is the sixth most common cancer, and the third most common cause of cancer related death worldwide. The multi-kinase inhibitor Sorafenib represents the only systemic treatment option until today, and results from clinical trials with allosteric mTOR inhibitors were sobering. Since the PI...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.12452

    authors: Ewald F,Nörz D,Grottke A,Bach J,Herzberger C,Hofmann BT,Nashan B,Jücker M

    更新日期:2015-09-16 00:00:00

  • Inhibition of malignant human bladder cancer phenotypes through the down-regulation of the long non-coding RNA SNHG7.

    abstract::There is abundant evidence that long non-coding RNAs play important roles in the development of tumors. In the present study, our main aim was to explore the relationship between lncRNA SNHG7 and human bladder cancer cells, thus finding a novel target for bladder cancer therapy and diagnosis. Expression of lncRNA SNHG...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.25507

    authors: Xu C,Zhou J,Wang Y,Wang A,Su L,Liu S,Kang X

    更新日期:2019-01-01 00:00:00

  • Risk of immune-related colitis with PD-1/PD-L1 inhibitors vs chemotherapy in solid tumors: systems assessment.

    abstract::Background: We performed a meta-analysis to evaluate the risk of immune-related colitis associated with PD1/PD-L1 inhibitors as compared to chemotherapy in solid tumor patients. Methods: Eligible studies were identified through a comprehensive search of multiple databases and included solid tumor patients in randomize...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.24200

    authors: Su Q,Zhang X,Shen X,Hou Y,Sun Z,Gao ZH

    更新日期:2018-04-12 00:00:00

  • Overexpression of Citron Rho-Interacting Serine/Threonine Kinase Associated with Poor Outcome in Bladder Cancer.

    abstract::Objective: Citron Rho-Interacting Serine/Threonine Kinase (CIT) was originally identified as a binding partner of active forms of the small GTPases Rho and Rac. This kinase participated in the regulation of cytokinesis and loss of CIT was associated with chromosomal instability. Here, we assume that CIT might be a pot...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.43435

    authors: Shou J,Yu C,Zhang D,Zhang Q

    更新日期:2020-04-14 00:00:00

  • Antitumor Activity of TAK-285, an Investigational, Non-Pgp Substrate HER2/EGFR Kinase Inhibitor, in Cultured Tumor Cells, Mouse and Rat Xenograft Tumors, and in an HER2-Positive Brain Metastasis Model.

    abstract::Breast cancer therapy has improved following the development of drugs with specific molecular targets, exemplified by inhibitors of human epidermal growth factor receptor-2 (HER2) or epidermal growth factor receptor (EGFR) such as trastuzumab and lapatinib. However, these drugs have little effect on brain metastasis d...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.6689

    authors: Nakayama A,Takagi S,Yusa T,Yaguchi M,Hayashi A,Tamura T,Kawakita Y,Ishikawa T,Ohta Y

    更新日期:2013-08-16 00:00:00

  • Non-pegylated liposomal Doxorubicin-cyclophosphamide in sequential regimens with taxanes as neoadjuvant chemotherapy in breast cancer patients.

    abstract:PURPOSE:Chemotherapy regimens containing anthracyclines and taxanes represent the landmark of neoadjuvant systemic therapy of breast cancer. In advanced breast cancer patients liposomal anthracyclines (LA) have shown similar efficacy and less cardiac toxicity when compared to conventional anthracyclines. We performed t...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.9132

    authors: Vici P,Pizzuti L,Gamucci T,Sergi D,Conti F,Zampa G,Del Medico P,De Vita R,Pozzi M,Botti C,Di Filippo S,Tomao F,Sperduti I,Di Lauro L

    更新日期:2014-04-25 00:00:00

  • MiR-217 Promotes Tumor Proliferation in Breast Cancer via Targeting DACH1.

    abstract:OBJECTIVE:The expression of DACH1 was frequently lost in human breast cancer, which significantly correlated with poor prognosis. Herein, we aim to investigate its underlying mechanisms. METHODS:The expression of miR-217 was detected by Taqman PCR. The mRNA and protein level of DACH1 were investigated by real time PCR...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.10822

    authors: Zhang Q,Yuan Y,Cui J,Xiao T,Jiang D

    更新日期:2015-01-01 00:00:00

  • Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation.

    abstract::Non-small cell lung cancer (NSCLC) is one of the most common types of aggressive cancer. The tumor tissue, which shows an active angiogenesis, is composed of neoplastic and stromal cells, and an abundant inflammatory infiltrate. Angiogenesis is important to support tumor growth, while infiltrating cells contribute to ...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.12286

    authors: Rivas-Fuentes S,Salgado-Aguayo A,Pertuz Belloso S,Gorocica Rosete P,Alvarado-Vásquez N,Aquino-Jarquin G

    更新日期:2015-08-07 00:00:00

  • Triple-high expression of phosphatase and tensin homolog (PTEN), estrogen receptor (ER) and progesterone receptor (PR) may predict favorable prognosis for patients with Type I endometrial carcinoma.

    abstract::Endometrial carcinoma (EC) is the most common malignant tumors in female derived from the endometrial epithelium. Several previous studies have described estrogen receptors (ER), progesterone Receptor (PR) and phosphatase and tensin homolog (PTEN) are associated with clinicopathological factors and prognosis in EC pat...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.33720

    authors: Liang Y,Lin B,Ye Z,Chen S,Yu H,Chen C,Zhang X,Zhou K,Zeng J

    更新日期:2020-01-13 00:00:00

  • The Immune Checkpoint Regulator PDL1 is an Independent Prognostic Biomarker for Biochemical Recurrence in Prostate Cancer Patients Following Adjuvant Hormonal Therapy.

    abstract::Background: The programmed death 1 (PD1)/programmed death ligand 1 (PDL1) targeted therapies have gained positive outcomes in several tumors, but the evidence of the expression and prognosis value of PD1/PDL1 in high risk prostate cancer was rare. Methods: Immunohistochemical analysis of PDL1/PD1 expression by a valid...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.30384

    authors: Li H,Wang Z,Zhang Y,Sun G,Ding B,Yan L,Liu H,Guan W,Hu Z,Wang S,Cheng F,Xu H,Zhang X,Ye Z

    更新日期:2019-06-02 00:00:00

  • Efficacy of Cabazitaxel Treatment in Metastatic Castration Resistant Prostate Cancer in Second and Later Lines. An Experience from Two German Centers.

    abstract::Purpose: Several new treatment options for patients with metastatic castration resistant prostate cancer (mCRPC) have been approved within the last years - among them cabazitaxel (CAB), abiraterone acetate, enzalutamide, and radium-223. The aim of this study was to assess factors predictive for efficacy of CAB. Method...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.17644

    authors: Zschäbitz S,Vallet S,Hadaschik B,Debatin D,Fuxius S,Karcher A,Pahernik S,Spath C,Duensing S,Jäger D,Hohenfellner M,Grüllich C

    更新日期:2017-02-11 00:00:00

  • MCMs expression in lung cancer: implication of prognostic significance.

    abstract::Minichromosome Maintenance (MCM) proteins play essential roles in various cancers. We previously reported that MCM7 could be a prognostic biomarker in non-small cell lung cancer (NSCLC). The purpose of current study is to explore roles of other MCM proteins in NSCLC and their correlation with clinico-pathologic parame...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.20777

    authors: Liu YZ,Wang BS,Jiang YY,Cao J,Hao JJ,Zhang Y,Xu X,Cai Y,Wang MR

    更新日期:2017-10-09 00:00:00

  • Comparison of clinical characteristics and survival after surgery in patients with non-B and non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma.

    abstract:BACKGROUND AND AIMS:We compared clinicopathologic data and long-term clinical outcomes among patients with non-B and non-C hepatocellular carcinoma (NBNC-HCC) who underwent curative resection (group A, n=129), those with hepatitis B virus-related HCC (group B, n=62) and those with hepatitis C virus-related HCC (group C...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.6503

    authors: Nishikawa H,Arimoto A,Wakasa T,Kita R,Kimura T,Osaki Y

    更新日期:2013-07-18 00:00:00

  • Plasma soluble PD-L1 and STAT3 predict the prognosis in diffuse large B cell lymphoma patients.

    abstract::Purpose: Diffuse large B cell lymphoma (DLBCL) is one of the most common B cell lymphomas, which displays heterogeneous pathologies. Programmed cell death 1/ programmed cell death ligand 1 (PD-1/PD-L1) plays an essential role in immunosuppression in multiple malignancies. Signal transducer and activator of transcripti...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.47816

    authors: Fei Y,Yu J,Li Y,Li L,Zhou S,Zhang T,Li L,Qiu L,Meng B,Pan Y,Ren X,Qian Z,Wang X,Zhang H

    更新日期:2020-10-17 00:00:00

  • Prognostic Impact of Thrombospodin-2 (THBS2) Overexpression on Patients with Urothelial Carcinomas of Upper Urinary Tracts and Bladders.

    abstract:PURPOSE:Urothelial carcinoma (UC) is a type of tumor, especially of the urinary bladder, that affects people worldwide. Clarification of its detailed tumor biology and discovery of potential targets for developing treatment strategies are imperative because of frequent recurrences and poor prognosis of advanced UCs. By...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.15696

    authors: Chang IW,Li CF,Lin VC,He HL,Liang PI,Wu WJ,Li CC,Huang CN

    更新日期:2016-07-08 00:00:00

  • Significantly higher pathologic complete response (pCR) after the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: Evidence from a meta-analysis of randomized controlled trials.

    abstract::Objectives: To investigate the effect of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy (NAC) for HER2-positive breast cancer in terms of pCR and cardiotoxicity. Methods: We systematically searched Pubmed, Embase, Cochrane and SinoMed databases from inception until 1 July 2017 for r...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.24701

    authors: Wu YT,Xu Z,Arshad B,Wu JS,Zhang K,Wu H,Li X,Li H,Li YC,Wang ZL,Wu KN,Kong LQ

    更新日期:2018-08-06 00:00:00

  • Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial.

    abstract::Background: Although biliary tract cancer (BTC) has a very aggressive nature, some patients maintain a relatively good performance status after failure with first-line treatment of gemcitabine plus cisplatin (GC). Thus, tolerable, feasible, and useful second-line treatments are needed for these patients. We investigat...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.37610

    authors: Kim ST,Oh SY,Lee J,Kang JH,Lee HW,Lee MA,Sohn BS,Hong JH,Park YS,Park JO,Lim HY

    更新日期:2019-10-15 00:00:00

  • Downregulation of miR-1 in colorectal cancer promotes radioresistance and aggressive phenotypes.

    abstract::Background: Colorectal cancer (CRC) remains to be one of the most common malignancies worldwide. Various studies have demonstrated that microRNAs (miRs) play a critical role in regulating cancer progression and sensitivity to chemoradiotherapy. miR-1 was found to be aberrantly expressed in CRC. However, it has not bee...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.44753

    authors: Wu Y,Pu N,Su W,Yang X,Xing C

    更新日期:2020-06-07 00:00:00

  • The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection.

    abstract::Background: The predictive roles of secreted protein acidic and rich in cysteine (SPARC) in pancreatic ductal adenocarcinoma (PDAC) patients after curative resection have not been clarified. We investigated the correlations between the SPARC expression and the postoperative prognosis. Methods: We retrospectively analy...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.28660

    authors: Murakawa M,Aoyama T,Miyagi Y,Kobayashi S,Ueno M,Morimoto M,Numata M,Yamamoto N,Tamagawa H,Yukawa N,Rino Y,Masuda M,Morinaga S

    更新日期:2019-01-01 00:00:00

  • Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? - Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) Database.

    abstract:OBJECTIVE:To elucidate the oncologic behavior of Micropapillary Urothelial Bladder Carcinoma (MPBC), a rare aggressive variant histology. METHODS:All MPBC patients in SEER 17 database were compared with those with traditional urothelial carcinoma (UC). Kaplan-Meier curves were used to determine OS and CSS. A Cox propo...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.6215

    authors: Vourganti S,Harbin A,Singer EA,Shuch B,Metwalli AR,Agarwal PK

    更新日期:2013-05-06 00:00:00

  • Synergy of purine-scaffold TLR7 agonist with doxorubicin on systemic inhibition of lymphoma in mouse model.

    abstract::Chemo- and radio-therapy suffer from certain well-recognized drawbacks for lymphoma therapy. Passive immunotherapy with monoclonal antibody has improved outcome for patients with CD20+ B cell lymphoma, but not for T cell lymphoma. Therefore, novel treatment approaches are clearly required for T cell lymphoma. To date,...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.20015

    authors: Gao D,Li W,Wang W,Cai Y,Wang Y,Luo X,Wei CC

    更新日期:2017-09-15 00:00:00

  • Consistency Analysis of Programmed Death-Ligand 1 Expression between Primary and Metastatic Non-Small Cell Lung Cancer: A Retrospective Study.

    abstract::Background: Programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer (NSCLC) is considered as a predictive biomarker of anti-PD-1/PD-L1 cancer therapies. However, the correlation of PD-L1 expression status between the primary and paired metastatic NSCLC is still not clear. The current study aims to a...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.34793

    authors: Luo L,Luo X,Chen W,Liang C,Yao S,Huang W,Liu C,Ge Y,Lin X,Li Z

    更新日期:2020-01-01 00:00:00

  • Association between APE1 Single Nucleotide Polymorphism (rs1760944) and Cancer Risk: a Meta-Analysis Based on 6,419 Cancer Cases and 6,781 Case-free Controls.

    abstract::Apurinic/apyrimidinic endonuclease 1 (APE1) is an essential enzyme in the base excision repair pathway. Epidemiological studies have suggested associations between APE1 rs1760944 polymorphism and cancer risk. This study was aimed to evaluate the relationship between APE1 rs1760944 polymorphism and cancer risk. We sear...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.8085

    authors: Dai ZJ,Wang XJ,Kang AJ,Ma XB,Min WL,Lin S,Zhao Y,Yang PT,Wang M,Kang HF

    更新日期:2014-03-13 00:00:00